Abstract
Summary
The global market for Sartans API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sartans API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sartans API by region & country, by Type, and by Application.
The Sartans API market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sartans API.
Market Segmentation
By Company
Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Segment by Type:
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Segment by Application
Anti-Hypertension
Anti-Viral
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sartans API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sartans API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sartans API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sartans API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sartans API by region & country, by Type, and by Application.
The Sartans API market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sartans API.
Market Segmentation
By Company
Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Segment by Type:
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Segment by Application
Anti-Hypertension
Anti-Viral
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sartans API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sartans API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sartans API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Sartans API Product Introduction
1.2 Global Sartans API Market Size Forecast
1.2.1 Global Sartans API Sales Value (2019-2030)
1.2.2 Global Sartans API Sales Volume (2019-2030)
1.2.3 Global Sartans API Sales Price (2019-2030)
1.3 Sartans API Market Trends & Drivers
1.3.1 Sartans API Industry Trends
1.3.2 Sartans API Market Drivers & Opportunity
1.3.3 Sartans API Market Challenges
1.3.4 Sartans API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sartans API Players Revenue Ranking (2023)
2.2 Global Sartans API Revenue by Company (2019-2024)
2.3 Global Sartans API Players Sales Volume Ranking (2023)
2.4 Global Sartans API Sales Volume by Company Players (2019-2024)
2.5 Global Sartans API Average Price by Company (2019-2024)
2.6 Key Manufacturers Sartans API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sartans API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sartans API
2.9 Sartans API Market Competitive Analysis
2.9.1 Sartans API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sartans API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sartans API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Valsartan
3.1.2 Irbesartan
3.1.3 Telmisartan
3.1.4 Losartan
3.1.5 Others
3.2 Global Sartans API Sales Value by Type
3.2.1 Global Sartans API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sartans API Sales Value, by Type (2019-2030)
3.2.3 Global Sartans API Sales Value, by Type (%) (2019-2030)
3.3 Global Sartans API Sales Volume by Type
3.3.1 Global Sartans API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sartans API Sales Volume, by Type (2019-2030)
3.3.3 Global Sartans API Sales Volume, by Type (%) (2019-2030)
3.4 Global Sartans API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Anti-Hypertension
4.1.2 Anti-Viral
4.1.3 Others
4.2 Global Sartans API Sales Value by Application
4.2.1 Global Sartans API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sartans API Sales Value, by Application (2019-2030)
4.2.3 Global Sartans API Sales Value, by Application (%) (2019-2030)
4.3 Global Sartans API Sales Volume by Application
4.3.1 Global Sartans API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sartans API Sales Volume, by Application (2019-2030)
4.3.3 Global Sartans API Sales Volume, by Application (%) (2019-2030)
4.4 Global Sartans API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sartans API Sales Value by Region
5.1.1 Global Sartans API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sartans API Sales Value by Region (2019-2024)
5.1.3 Global Sartans API Sales Value by Region (2025-2030)
5.1.4 Global Sartans API Sales Value by Region (%), (2019-2030)
5.2 Global Sartans API Sales Volume by Region
5.2.1 Global Sartans API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sartans API Sales Volume by Region (2019-2024)
5.2.3 Global Sartans API Sales Volume by Region (2025-2030)
5.2.4 Global Sartans API Sales Volume by Region (%), (2019-2030)
5.3 Global Sartans API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sartans API Sales Value, 2019-2030
5.4.2 North America Sartans API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sartans API Sales Value, 2019-2030
5.5.2 Europe Sartans API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sartans API Sales Value, 2019-2030
5.6.2 Asia Pacific Sartans API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sartans API Sales Value, 2019-2030
5.7.2 South America Sartans API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sartans API Sales Value, 2019-2030
5.8.2 Middle East & Africa Sartans API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sartans API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sartans API Sales Value
6.2.1 Key Countries/Regions Sartans API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sartans API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sartans API Sales Value, 2019-2030
6.3.2 United States Sartans API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sartans API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sartans API Sales Value, 2019-2030
6.4.2 Europe Sartans API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sartans API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sartans API Sales Value, 2019-2030
6.5.2 China Sartans API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sartans API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sartans API Sales Value, 2019-2030
6.6.2 Japan Sartans API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sartans API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sartans API Sales Value, 2019-2030
6.7.2 South Korea Sartans API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sartans API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sartans API Sales Value, 2019-2030
6.8.2 Southeast Asia Sartans API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sartans API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sartans API Sales Value, 2019-2030
6.9.2 India Sartans API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sartans API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Sartans API Product Offerings
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Introduction and Business Overview
7.2.3 Novartis Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis Sartans API Product Offerings
7.2.5 Novartis Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Sartans API Product Offerings
7.3.5 Merck Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Company Information
7.4.2 AstraZeneca Introduction and Business Overview
7.4.3 AstraZeneca Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AstraZeneca Sartans API Product Offerings
7.4.5 AstraZeneca Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Information
7.5.2 Eli Lilly Introduction and Business Overview
7.5.3 Eli Lilly Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Eli Lilly Sartans API Product Offerings
7.5.5 Eli Lilly Recent Development
7.6 Sanofi
7.6.1 Sanofi Company Information
7.6.2 Sanofi Introduction and Business Overview
7.6.3 Sanofi Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sanofi Sartans API Product Offerings
7.6.5 Sanofi Recent Development
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Information
7.7.2 Bristol-Myers Squibb Introduction and Business Overview
7.7.3 Bristol-Myers Squibb Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bristol-Myers Squibb Sartans API Product Offerings
7.7.5 Bristol-Myers Squibb Recent Development
7.8 Bayer
7.8.1 Bayer Company Information
7.8.2 Bayer Introduction and Business Overview
7.8.3 Bayer Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bayer Sartans API Product Offerings
7.8.5 Bayer Recent Development
7.9 GSK
7.9.1 GSK Company Information
7.9.2 GSK Introduction and Business Overview
7.9.3 GSK Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 GSK Sartans API Product Offerings
7.9.5 GSK Recent Development
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Information
7.10.2 Teva Pharmaceutical Introduction and Business Overview
7.10.3 Teva Pharmaceutical Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Pharmaceutical Sartans API Product Offerings
7.10.5 Teva Pharmaceutical Recent Development
7.11 Xianju Pharma
7.11.1 Xianju Pharma Company Information
7.11.2 Xianju Pharma Introduction and Business Overview
7.11.3 Xianju Pharma Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Xianju Pharma Sartans API Product Offerings
7.11.5 Xianju Pharma Recent Development
7.12 Menovo
7.12.1 Menovo Company Information
7.12.2 Menovo Introduction and Business Overview
7.12.3 Menovo Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Menovo Sartans API Product Offerings
7.12.5 Menovo Recent Development
7.13 Tianyu Pharma
7.13.1 Tianyu Pharma Company Information
7.13.2 Tianyu Pharma Introduction and Business Overview
7.13.3 Tianyu Pharma Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Tianyu Pharma Sartans API Product Offerings
7.13.5 Tianyu Pharma Recent Development
7.14 Starry Pharma
7.14.1 Starry Pharma Company Information
7.14.2 Starry Pharma Introduction and Business Overview
7.14.3 Starry Pharma Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Starry Pharma Sartans API Product Offerings
7.14.5 Starry Pharma Recent Development
7.15 Huahai Pharmaceutical
7.15.1 Huahai Pharmaceutical Company Information
7.15.2 Huahai Pharmaceutical Introduction and Business Overview
7.15.3 Huahai Pharmaceutical Sartans API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Huahai Pharmaceutical Sartans API Product Offerings
7.15.5 Huahai Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Sartans API Industrial Chain
8.2 Sartans API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sartans API Sales Model
8.5.2 Sales Channel
8.5.3 Sartans API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer